YAP1 and cancer: Dysregulation of this pathway in cancer increases the ability of YAP/TAZ oncoproteins to translocate to the nucleus and act as co-factors, inducing the expression of a core of oncogenic genes: cell-proliferative and anti-apoptotic genes, for instance [8].